Hello everyone! Another J.P. Morgan Healthcare Conference has come and gone. Overall, it was chaotic but productive for Massive Bio. There were no game changing learning experiences for our core which is precision oncology informatics services, maybe because we live and breathe this space every day. However, the necessity of Massive Bio increases everyday to streamline disparate clinical and genomic information and disparate stakeholders. Precision oncology needs a translator and accelerator more than ever to be mainstream. Massive Bio put precision oncology to “work” — organizes and harmonizes disparate knowledge into clinical utility. In any case, I have summarized our key take-aways from the conference in regards to our space, digital health and AI and overall healthcare. Hope you will find it as an enjoyable read and I am always happy to have a dialogue and attack healthcare issues with like minded people together.
We continue to support you and your loved ones by sharing new savings.
Mention "Happy Valentine's Day" when you call us at 1 844 627 7246.
Give a gift to your loved one who is fighting cancer. Unlock meaningful time and help your loved one to apply the latest scientific knowledge to his/her case. Massive Bio collects and curates the latest scientific knowledge in genomics of cancer, connects with your loved one's clinical information and supports your loved one and his/her treating oncologist to incorporate all new discoveries into the treatment plan.
There are over 13,000 women diagnosed with cervical cancer each year in the United States alone. In fact, even with early detection, it is estimated that there will be 13,240 new cases of invasive cervical cancer detected in 2018. In the past, cervical cancer was a leading cause of death for American women, however, it can now be prevented with the use of the Pap Smear and the HPV vaccination. Cervical cancer generally occurs in middle aged women, but it can still present itself in younger or older women who have not been screened regularly.
Massive Biois driven to provide cancer patients, their families and trusted treating oncologists a service that will generate the most current precise oncology plan without disrupting their lives, relocating or financially hindering them.